SCHEMBL13554698

SCHEMBL13554698

c1ccc(-c2cccc3nc4c5nc6cccc(-c7ccccn7)c6nc5c5nc6c(-c7ccccn7)ccc(-c7ccccn7)c6nc5c4nc23)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.48
SMN1; SMN2 Q16637 7/20 0.48
LMNA P02545 6/20 0.48
TP53 P04637 6/20 0.48
L3MBTL1 Q9Y468 4/20 0.48
CCR1 P32246 3/20 0.48
CCR5 P51681 3/20 0.48
CCR8 P51685 3/20 0.48
HTT P42858 3/20 0.48
ALOX15 P16050 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
MAPK1 P28482 2/20 0.48
ALPL P05186 1/20 0.48
HSP90AA1 P07900 1/20 0.48
ALPI P09923 1/20 0.48
ALPG P10696 1/20 0.48
METAP1 P53582 3/20 0.45
CYP1A2 P05177 2/20 0.45
HIF1A Q16665 2/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1704912 0.91 KDM4E (0.50) KDM4ESMN1; SMN2LMNATP53L3MBTL1
SCHEMBL3432187 0.89 KDM4E (0.48) KDM4ESMN1; SMN2LMNATP53L3MBTL1
SCHEMBL13554704 0.87 KDM4E (0.59) KDM4ESMN1; SMN2LMNATP53L3MBTL1
SCHEMBL25380095 0.79 KDM4E (0.45) KDM4ESMN1; SMN2LMNATP53L3MBTL1
SCHEMBL21297352 0.78 TOP1 (0.34) KDM4ESMN1; SMN2LMNAL3MBTL1HTT
SCHEMBL16512102 0.76 KDM4E (0.58) KDM4ESMN1; SMN2LMNATP53L3MBTL1
SCHEMBL27924279 0.74 KDM4E (0.65) KDM4ESMN1; SMN2LMNATP53L3MBTL1
SCHEMBL858806 0.73 KDM4E (0.72) KDM4ESMN1; SMN2LMNATP53L3MBTL1
SCHEMBL27837532 0.72 METAP2 (0.63) KDM4ESMN1; SMN2LMNATP53L3MBTL1
SCHEMBL26259997 0.72 KDM4E (0.62) KDM4ESMN1; SMN2LMNATP53L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140066290-A1 CATHODE CATALYST FOR AIR SECONDARY BATTERY AND AIR SECONDARY BATTERY SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-03-06 US disclosed
US-20140066290-A1 CATHODE CATALYST FOR AIR SECONDARY BATTERY AND AIR SECONDARY BATTERY SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-03-06 US disclosed
US-20120270141-A1 NITROGEN-CONTAINING AROMATIC COMPOUNDS AND METAL COMPLEXES MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) 2012-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270141-A1 NITROGEN-CONTAINING AROMATIC COMPOUNDS AND METAL COMPLEXES TYR, MT-CO2, SOD1 KDM4E 563/4885SMN1; SMN2 3076/4885LMNA 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.